STAT4 and chronic kidney disease: SDMA inhibits partial EMT and attenuates renal tubulointerstitial fibrosis through inhibition of STAT4 (Fig. 6), suggesting that enhancing renal SDMA production or inhibition of STAT4 could be a new strategy to treat CKD patients with renal tubulointerstitial fibrosis.